Cargando…

Advances in the Development of Biotherapeutics

Detalles Bibliográficos
Autores principales:	Oliveira, Pedro H., Mairhofer, Juergen, Alves, Paula M., Lara, Alvaro R., Kontoravdi, Cleo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453278/ https://www.ncbi.nlm.nih.gov/pubmed/26078963 http://dx.doi.org/10.1155/2015/793876

Ejemplares similares

The Development Pathway for Biosimilar Biotherapeutics
por: Zarbin, Marco
Publicado: (2020)

Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development
por: Lu, Yanmei, et al.
Publicado: (2016)

In vivo selection of novel biotherapeutics
por: Ruozi, Giulia, et al.
Publicado: (2015)

Towards advanced bioprocess optimization: A multiscale modelling approach
por: Monteiro, Mariana, et al.
Publicado: (2023)

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
por: Zhong, Xiaotian, et al.
Publicado: (2021)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Tackling Multidrug Resistance in Streptococci – From Novel Biotherapeutic Strategies to Nanomedicines
por: Alves-Barroco, Cinthia, et al.
Publicado: (2020)

Recent advances in the treatment of C. difficile using biotherapeutic agents
por: Giau, Vo Van, et al.
Publicado: (2019)

Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics
por: Chang, Rachel Yoon Kyung, et al.
Publicado: (2022)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)

Harnessing the potential of artificial neural networks for predicting protein glycosylation
por: Kotidis, Pavlos, et al.
Publicado: (2020)

Population balance modelling captures host cell protein dynamics in CHO cell cultures
por: Alhuthali, Sakhr, et al.
Publicado: (2022)

Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective
por: Flevaris, Konstantinos, et al.
Publicado: (2022)

Analytical Workflows to Unlock Predictive Power in Biotherapeutic Developability
por: Trikeriotis, Markos, et al.
Publicado: (2022)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
por: Jefferis, Roy
Publicado: (2016)

The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021)

Editorial: Characterization of biotherapeutic products
por: Rathore, Anurag S., et al.
Publicado: (2022)

The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development
por: Doocey, Claire M., et al.
Publicado: (2022)

Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates
por: Hong, Paula, et al.
Publicado: (2012)

Recent Advances in the Treatment of C. difficile Using Biotherapeutic Agents [Corrigendum]
Publicado: (2021)

Aggregation risk prediction for antibodies and its application to biotherapeutic development
por: Obrezanova, Olga, et al.
Publicado: (2015)

Development of mucoadhesive adapalene gel for biotherapeutic delivery to vaginal tissue
por: Afzaal, Hasan, et al.
Publicado: (2022)

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
por: Sauna, Zuben E., et al.
Publicado: (2023)

How can we discover developable antibody-based biotherapeutics?
por: Bauer, Joschka, et al.
Publicado: (2023)

Rapid development and deployment of high‐volume vaccines for pandemic response
por: Kis, Zoltán, et al.
Publicado: (2020)

Pediatric Dosing and Body Size in Biotherapeutics
por: Shi, Rong, et al.
Publicado: (2010)

Regulatory Pathway for Licensing Biotherapeutics in Mexico
por: López-Morales, Carlos A., et al.
Publicado: (2018)

Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
por: Husain, Bushra, et al.
Publicado: (2018)

Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins
por: Betterle, Nico, et al.
Publicado: (2020)

IgY Antibodies as Biotherapeutics in Biomedicine
por: León-Núñez, Diana, et al.
Publicado: (2022)

Modelling of amorphous cellulose depolymerisation by cellulases, parametric studies and optimisation
por: Niu, Hongxing, et al.
Publicado: (2016)

Osmolality Effects on CHO Cell Growth, Cell Volume, Antibody Productivity and Glycosylation
por: Alhuthali, Sakhr, et al.
Publicado: (2021)

In Situ Monitoring of Intracellular Glucose and Glutamine in CHO Cell Culture
por: Behjousiar, Alireza, et al.
Publicado: (2012)

Dynamic profiling of amino acid transport and metabolism in Chinese hamster ovary cell culture
por: Kyriakopoulos, Sarantos, et al.
Publicado: (2013)

Glycoengineering Chinese hamster ovary cells: a short history
por: Donini, Roberto, et al.
Publicado: (2021)

Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash, Satya, et al.
Publicado: (2011)

Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities
por: Wang, Xiangdan, et al.
Publicado: (2020)

Strategies in developing dimethyl sulfoxide (DMSO)-free cryopreservation protocols for biotherapeutics
por: Ekpo, Marlene Davis, et al.
Publicado: (2022)

An improved model framework linking the extracellular environment to antibody glycosylation
por: Jedrzejewski, Philip M, et al.
Publicado: (2015)

Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography
por: Goey, Cher Hui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o2gb536t26bakg0449jn2frsr6